MS&L loses Nasse to Huntsworth

Huntsworth Health has swooped for Manning Selvage & Lee's director of medical affairs Guy Nasse.

Nasse: 20 years’ experience
Nasse: 20 years’ experience

Taking the newly created post of associate director, Nasse will manage PR and medical education accounts out of Huntsworth’s Chiswick office.

He will start on 3 September, reporting to commercial director Sandy Thomson who is based at the company’s Marlow office. Thomson said Nasse would ‘drive the agency’s PR capability and add to its global offering’.

With more than 20 years’ experience in the pharmaceuticals industry, Nasse has worked for the past nine years on global PR accounts at MS&L.

Most recently he has foc­used on the Sanofi-Aventis account working in areas such as NICE approvals across its oncology portfolio. He has also handled the Eli Lilly account working on the osteoporosis drug Forteo and the erectile dysfunction remedy Cialis.

Prior to joining MS&L, Nasse worked with Shandwick Health as account dir­ector for its global healthcare taskforce across neurology, infertility and medical device ranges. His responsibilities at Shandwick included the co-ordination of healthcare accounts, media releases, stakeholder management and the internal and external issues management.

The appointment comes as Huntsworth Health is exp­anding its business on the back of account wins and overseas acquisitions.

In July it bought US healthcare agency AXIS Healthcare Communications for £9.2m – an acquisition that followed its purchase of Dorland Global Corporation in March (PRWeek, 16 March).

‘We have had recent wins in the areas of women’s health, cardiology and anaesthesia,’ said Thomson. ‘This year has also seen the acquisition of the medical communications agencies Dorland and Axis. Guy will help to integrate a global offering across all three organisations.’

In addition to his PR role, Nasse’s medical education activities will involve meetings and symposiums, the education of clinicians, and working with advocates in specific therapeutic areas to develop opinion leaders for new products.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in